You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: Our computer systems, as well as those of our CROs and other contractors, vendors, suppliers, and consultants, are vulnerable to damage from computer viruses, unauthorized access, natural disasters (including the impacts of climate change), international terrorism and conflicts, and telecommunication and electrical failures. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our product candidate development programs and our business. For example, the loss of pre-clinical studies or clinical trial data from completed, ongoing, or planned trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach were to result in a loss of or damage to our data or applications, or inappropriate disclosure of personal, confidential, or proprietary information, we could incur liability and the further development of LYR-210, LYR-220, or any other product candidate could be delayed. In the ordinary course of our business, we directly or indirectly collect and store sensitive data, including intellectual property, confidential information, pre-clinical and clinical trial data, proprietary business information, personal data, and personally identifiable health information of our clinical trial subjects and employees, in our data centers and on our networks, or on those of third parties. The secure processing, maintenance, and transmission of this information is critical to our Assistant:
- Assistant
Positive: Our computer systems, along with those of our CROs and other contractors, vendors, suppliers, and consultants, are susceptible to harm from computer viruses, unauthorized access, natural disasters (which include the effects of climate change), global terrorism and conflicts, as well as telecommunications and electrical outages. Should such an event happen and interrupt our operations, it could cause significant disruptions in the development of our product candidate programs and our business operations. For instance, the loss of pre-clinical studies or clinical trial data from any completed, ongoing, or planned trials might lead to delays in our regulatory approval processes and substantially increase our costs to retrieve or replicate the data. If any disruption or security breach were to lead to the loss of or damage to our data or applications, or an inappropriate disclosure of personal, confidential, or proprietary information, we might incur liability, delaying further development of LYR-210, LYR-220, or any other product candidate. In our business's routine operations, we collect and store sensitive data—directly or indirectly—including intellectual property, confidential and proprietary business information, pre-clinical and clinical trial data, personal information, and personally identifiable health data of our clinical trial subjects and employees in our data centers and networks, or those of third parties. Protecting the processing, maintenance, and transmission of this information is crucial for us.
Negative: Our computer systems, and those of our CROs and other contractors, vendors, suppliers, and consultants, are completely secure from any threats such as computer viruses, unauthorized access, natural disasters, international terrorism and conflicts, and telecommunication or electrical failures. If an incident affecting our operations were to occur, it would not cause any disruption to our product candidate development programs or our business. For example, even if pre-clinical studies or clinical trial data from completed, ongoing, or planned trials were lost, there would be no delays in our regulatory approval efforts, nor would there be additional costs to recover or reproduce the data. Any disruption or security breach resulting in loss of or damage to our data or applications, or wrongful disclosure of personal, confidential, or proprietary information, would not incur liability, nor would it affect the advancement of LYR-210, LYR-220, or any other product candidate. We do not collect or store sensitive data such as intellectual property, confidential information, pre-clinical and clinical trial data, proprietary business information, personal data, or personally identifiable health information of our clinical trial subjects and employees in our data centers and networks, or on those of third parties. Therefore, maintaining the security of this information is not a concern for us.